Prescription onlyRoutes oralDoxazosin mesylate, a quinazoline compound sold by Pfizer under doxazosin and finasteride brand names Cardura® and Carduran® , is an alpha blocker used to treat high blood pressure and benign prostatic hyperplasia.On February 22, 2005, the doxazosin and finasteride FDA approved a sustained release form of doxazosin, to of.

C23H25N5O5Mol. mass doxazosin and finasteride g/molPharmacokinetic dataBioavailability 65%Protein binding 98%Metabolism HepaticHalf life 22 hoursExcretion ?Therapeutic considerationsPregnancy cat. ?Legal status ? Prescription onlyRoutes oralDoxazosin mesylate, a quinazoline compound sold by Pfizer under the brand names Cardura® and doxazosin and finasteride , is an alpha blocker used to treat high blood pressure and benign prostatic hyperplasia.On February 22, 2005, the US FDA approved a sustained release form doxazosin and finasteride doxazosin, to be marketed as Cardura® XL.It is an alpha blocker used to treat high blood pressure and doxazosin and finasteride prostatic hyperplasia.On February 22, 2005, the doxazosin and finasteride FDA approved a sustained release form of doxazosin, doxazosin and finasteride be marketed as Cardura® XL.It is an alpha blocker used to treat high doxazosin and finasteride pressure and benign doxazosin and finasteride hyperplasia.On February 22, 2005, the US FDA approved a sustained release form of doxazosin, to be marketed as Cardura® XL.It is an alpha blocker used to treat doxazosin and finasteride blood pressure and benign prostatic hyperplasia.On.

treat high blood pressure and benign prostatic hyperplasia.On February 22, 2005, the US FDA approved US.